The use of percutaneous ventricular assist devices (PVADs) has grown by leaps and bounds in recent years, but a study published online March 30 in JAMA Internal Medicine casts doubt on their overall benefit, given the high costs and mortality rates.
Short hospital stays following PCI may be safe for older patients with STEMI. However, researchers caution stays of less than 48 hours may increase risk for 30-day mortality and major adverse cardiac events.
Multisite patient-centered disease management may not be able to compete with the level of care patients already receive at Veterans Affairs medical centers. At one year, cardiomyopathy scores for heart failure patients in an intervention arm were no better than those getting usual care.